CompletedPhase 2NCT00004217
S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- SWOG Cancer Research Network
- Principal Investigator
- Thomas R. Chauncey, MD, PhD, Ph.DVA Puget Sound Health Care System
- Intervention
- filgrastim(biological)
- Enrollment
- 55 enrolled
- Eligibility
- 56 years · All sexes
- Timeline
- 2000 – 2006
Study locations (30)
- MBCCOP - University of South Alabama, Mobile, Alabama, United States
- CCOP - Greater Phoenix, Phoenix, Arizona, United States
- Veterans Affairs Medical Center - Phoenix (Hayden), Phoenix, Arizona, United States
- Veterans Affairs Medical Center - Tucson, Tucson, Arizona, United States
- Arizona Cancer Center, Tucson, Arizona, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Veterans Affairs Medical Center - Little Rock (McClellan), Little Rock, Arkansas, United States
- Veterans Affairs Medical Center - Long Beach, Long Beach, California, United States
- USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
- Beckman Research Institute, City of Hope, Los Angeles, California, United States
- Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States
- CCOP - Bay Area Tumor Institute, Oakland, California, United States
- Chao Family Comprehensive Cancer Center, Orange, California, United States
- University of California Davis Medical Center, Sacramento, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00004217 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.